CHINA NATIONAL MEDICINES CORPORATION LTD.

Other languages China National Medicines Corporation Ltd.

Equities

600511

CNE000001D56

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-06-04 pm EDT			5-day change	1st Jan Change
34.8 ^CNY	-0.77%		+0.84%	+21.59%

Apr. 25	China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 21	China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	Mar. 21
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	Mar. 21
China National Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20
China National Medicines Deputy Manager Under Probe for Alleged Insider Trading	Jan. 10
CASI Pharmaceuticals, Inc. Enters into an Exclusive Distribution Agreement with China National Medicines Corporation Ltd	Dec. 08
China National Medicines' Profit Drops 16.1% in Q3	23-10-25
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24
Sinopharm CFO Retires; Successor Named	23-10-16
China National Medicines' Profit Climbs 14.2% in H1	23-08-24
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23
China National Medicines' Q1 Profit Rises 10.9%	23-04-25
China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25
Sinopharm’s Profit Rises 12% in 2022; Revenue Slips 2%	23-03-23
China National Medicines' 2022 Profit Up 12%	23-03-23
Sinopharm Eyes Production of Merck's COVID-19 Drug in China	23-01-13
Sinopharm Clarifies It Is Not A Distributor for Pfizer's COVID-19 Drug	22-12-20
Sinopharm to Buy $168 Million Shares in Shyndec Pharma	22-11-30
Sinopharm Unit Wins Nod to Launch Clinical Trial of COVID-19 Nasal Drug	22-11-29
China National Medicines' Q3 Profit Rises 6%	22-10-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages China National Medicines Corporation Ltd.

Equities

600511

CNE000001D56

Other languages

Filters